<DOC>
	<DOCNO>NCT00191698</DOCNO>
	<brief_summary>The purpose trial test effectiveness atomoxetine treat symptom ODD child ADHD ODD .</brief_summary>
	<brief_title>Comparison Atomoxetine Placebo Children Adolescents With ADHD ODD</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Attention Deficit Disruptive Behavior Disorders</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Patients male female outpatient least 6 year age 12 year age study entry . Patients must meet DSMIV diagnostic criterion ADHD ODD . If comorbid condition present , either ADHD ODD diagnosis must patient 's primary diagnosis . Patients must laboratory result , include serum chemistry , hematology , urinalysis show significant abnormality . Patients must ECG perform study entry absent abnormality , opinion physician , exclude patient . Patients weigh less 20 kg great 60 kg study entry . Patients history Bipolar I II disorder , psychosis , pervasive developmental disorder . Patients current diagnosis Major Depressive Disorder ( [ MDD ] ; without psychotic feature ) , PTSD , CDRSR total raw score &gt; 40 study entry . Patients history seizure disorder . Patients determine investigator serious suicidal risk .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>October 2008</verification_date>
</DOC>